Advertisement

Current Infectious Disease Reports

, Volume 2, Issue 1, pp 78–83 | Cite as

Probiotics in the treatment of diarrheal diseases

  • Gregor Reid
Article

Abstract

Infections of the gastrointestinal tract are a major health problem worldwide, and many result in death, especially in the Third World. The approach to treatment and prevention of these infections has revolved around antibiotic administration for many years, but the emergence of multidrug-resistant pathogens is forcing people to look at alternatives to antibiotics. For more than 100 years, probiotic remedies (viable organisms that benefit the host by improving the microbial balance) have been used to fight infection. Now, substantial scientific and clinical evidence indicates that certain well-selected probiotic organisms can reduce the risk and duration of diarrhea.

Keywords

Lactobacillus Lactic Acid Bacterium Diarrheal Disease Lactobacillus Acidophilus Lactobacillus Reuteri 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Ziemer CJ, Gibson GR: An overview of probiotics, prebiotics and synbiotics in the functional food concept: perspectives and future strategies. Int Dairy J 1998, 8:473–479.CrossRefGoogle Scholar
  2. 2.
    Franz CM, Holzapfel WH, Stiles ME: Enterococci at the crossroads of food safety? Int J Food Microbiol 1999, 47:1–24.PubMedCrossRefGoogle Scholar
  3. 3.
    Roberfroid MB: Prebiotics and synbiotics: concepts and nutritional properties. Br J Nutr 1998, 80:S197-S202.PubMedGoogle Scholar
  4. 4.
    Klein G, Pack A, Bonoparte C, Reuter G: Taxonomy and physiology of probiotic lactic acid bacteria. Int J Food Microbiol 1998, 41:103–125.PubMedCrossRefGoogle Scholar
  5. 5.
    Zhong W, Millsap K, Bialkowska-Hobrzanska H, Reid G: Differentiation of Lactobacillus species by molecular typing. Appl Environ Microbiol 1998, 64:2418–2423.PubMedGoogle Scholar
  6. 6.
    Reid G: The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol 1999, 65:3763–3766. Several authors have stated the characteristics that are currently thought to be important for effectiveness in a probiotic, but this is the first study to 1) analyze the strains being studied or sold as products, and 2) determine which strains fit the criteria for probiotics. Only seven strains fit the criteria at present.PubMedGoogle Scholar
  7. 7.
    Sanders ME: Development of consumer probiotics for the US market. Br J Nutr 1998, 80:S213-S218.PubMedGoogle Scholar
  8. 8.
    Naidu AS, Bidlack WR, Clemens RA: Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr 1999, 39:13–126.PubMedCrossRefGoogle Scholar
  9. 9.
    Canganella F, Paganini S, Ovidi M, et al.: A microbiology investigation on probiotic pharmaceutical products used for human health. Microbiol Res 1997, 152:171–179.PubMedGoogle Scholar
  10. 10.
    Schillinger U: Isolation and identification of lactobacilli from novel-type probiotic and mild yoghurts and their stability during refrigerated storage. Int J Food Microbiol 1999, 47:79–87.PubMedCrossRefGoogle Scholar
  11. 11.
    Gusils C, Perez Chaia A, Gonzalez S, Oliver G: Lactobacilli isolated from chicken intestines: potential use as probiotics. J Food Protection 1999, 62:252–256.Google Scholar
  12. 12.
    Tuomola EM, Salminen SJ: Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol 1998, 41:45–51.PubMedCrossRefGoogle Scholar
  13. 13.
    Kirjavainen PV, Ouwehand AC, Isolauri E, Salminen SJ: The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol Lett 1998, 167:185–189.PubMedCrossRefGoogle Scholar
  14. 14.
    Velraeds MC, van der Belt B, van der Mei HC, et al.: Interference in initial adhesion of uropathogenic bacteria and yeasts silicone rubber by a Lactobacillus acidophilus biosurfactant. J Med Microbiol 1998, 49:790–794.Google Scholar
  15. 15.
    Bengmark S: Immunonutrition: role of biosurfactants, fiber, and probiotic bacteria. Nutrition 1998, 14:585–594. This interesting paper brings together aspects of nutrition (and, therefore, possible prebiotic supplements), probiotics, and host mucosa.PubMedCrossRefGoogle Scholar
  16. 16.
    Koga T, Mizobe T, Takumi K: Antibacterial activity of Lactobacillus species against Vibrio species. Microbiol Res 1998, 153:271–275.PubMedGoogle Scholar
  17. 17.
    Ganzle MG, Weber S, Hammes WP: Effect of ecological factors on the inhibitory spectrum and activity of bacteriocins. Int J Food Microbiol 1999, 46:207–217.PubMedCrossRefGoogle Scholar
  18. 18.
    Charteris WP, Kelly PM, Morelli L, Collins JK: Antibiotic susceptibility of potentially probiotic Lactobacillus species. J Food Protection 1998, 61:1636–1643.Google Scholar
  19. 19.
    Johansson ML, Nobaek S, Berggren A, et al.: Survival of Lactobacillus plantarum DSM 9843 (299v) and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats. Int J Food Microbiol 1998, 42:29–38.PubMedCrossRefGoogle Scholar
  20. 20.
    Dunn SR, Simenhoff ML, Ahmed KE, et al.: Effect of oral administration of freeze-dried Lactobacillus acidophilus on small bowel bacterial overgrowth in patients with end stage kidney disease: reducing uremic toxins and improving nutrition. Int Dairy J 1998, 8:545–553. This was an important clinical application of two products, one of which contained the well-characterized L. acidophilus NCFMℳ, to an ill patient population in which recovery is influenced by physiologic well being and nutrient intake. The clinical implication is that probiotics may have a place in the intensive care setting.CrossRefGoogle Scholar
  21. 21.
    Yuki N, Watanabe K, Mike A, et al.: Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from faeces and identification using monoclonal antibodies. Int J Food Microbiol 1999, 48:51–57. This important paper verifies, with a well-studied organism, that clinical outcome is improved with probiotic therapy, and uses an enzyme-linked immunosorbent assay method to verify survival of the ingested organisms.PubMedCrossRefGoogle Scholar
  22. 22.
    Shornikova AV, Casas IA, Isolauri E, et al.: Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr 1997, 24:399–404. This double-active clinical study in 40 children provided preliminary evidence that lactobacilli can affect viral gastritis.PubMedCrossRefGoogle Scholar
  23. 23.
    Shornikova AV, Casas IA, Mykkanen H, et al.: Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis 1997, 16:1103–1107. This is one of too few randomized, placebo-controlled trials of probiotics against diarrhea. The positive outcome seen provides a solid argument in favor of this approach to health restoration.CrossRefGoogle Scholar
  24. 24.
    Rani B, Khetarpaul N: Probiotic fermented food mixtures: possible applications in clinical anti-diarrhoea usage. Nutr Health 1998, 12:97–105.PubMedGoogle Scholar
  25. 25.
    Brashears MM, Reilly SS, Gilliland SE: Antagonistic action of cells of Lactobacillus lactis toward Escherichia coli O157:H7 on refrigerated raw chicken meat. J Food Protection 1998, 61:166–170.Google Scholar
  26. 26.
    Mack DR, Michail S, Wei S, et al.: Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999, 276:G941-G950.PubMedGoogle Scholar
  27. 27.
    Tachikawa T, Seo G, Nakazawa M, et al.: Estimation of probiotics by infection model of infant rabbit with enterohemorrhagic Escherichia coli O157:H7. Kansenshogaku Zasshi. 1998, 72:1300–1305.PubMedGoogle Scholar
  28. 28.
    Lodinova-Zadnikova R, Sonnenborn U, Tlaskalova H: Probiotics in E. coli infections in man. Vet Q 1998, 20:S78-S81.PubMedGoogle Scholar
  29. 29.
    Weinberg ED: The Lactobacillus anomaly: total iron abstinence. Perspect Biol Med 1997, 40:578–583.PubMedGoogle Scholar
  30. 30.
    Oberhelman RA, Gilman RH, Sheen P, et al.: A placebocontrolled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 1999, 134:1–2.CrossRefGoogle Scholar
  31. 31.
    Aiba Y, Suzuki N, Kabir AM, et al.: Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 1998, 93:2097–2101.PubMedCrossRefGoogle Scholar
  32. 32.
    Lykova EA, Bondarenko VM, Sidorenko SV, et al.: Combined antibacterial and probiotic therapy of Helicobacterassociated diseases in children. Zh Mikrobiol Epidemiol Immunobiol 1999, 2:76–81.PubMedGoogle Scholar
  33. 33.
    Borriello SP, Roffe C: The normal microflora and antibiotic-associated diarrhoea and colitis. In Medical Importance of the Normal Flora. Edited by Tannock GW. London: Kluwer Academic Publishers; 1999:371–387.Google Scholar
  34. 34.
    Lewis SJ, Potts LF, Barry RE: The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J Infect 1998, 36:171–174.PubMedCrossRefGoogle Scholar
  35. 35.
    Schiffrin EJ, Brassart D, Servin AL, et al.: Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 1997, 66:515S-520S.PubMedGoogle Scholar
  36. 36.
    Gill HS: Stimulation of the immune system by lactic cultures. Int Dairy J 1998, 8:535–544. This is an excellent review of a complex topic. It provides good detail on specific and nonspecific immunity and on the mechanisms by which probiotic organisms stimulate the immune system.CrossRefGoogle Scholar
  37. 37.
    Spanhaak S, Havenaar R, Schaafsma G: The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 1998, 52:899–907.PubMedCrossRefGoogle Scholar
  38. 38.
    Matsuzaki T: Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int J Food Microbiol 1998, 41:133–140.PubMedCrossRefGoogle Scholar
  39. 39.
    Kato I, Tanaka K, Yokokura T: Lactic acid bacterium potently induces the production of interleukin-12 and interferongamma by mouse splenocytes. Int J Immunopharmacol 1999, 21:121–131.PubMedCrossRefGoogle Scholar
  40. 40.
    Donnet-Hughes A, Rochat F, Serrant P, et al.: Modulation of nonspecific mechanisms of defense by lactic acid bacteria. J Dairy Sci 1999, 82:863–869.PubMedCrossRefGoogle Scholar
  41. 41.
    Fukoshima Y, Kawata Y, Hara H, et al.: Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998, 42:39–44.CrossRefGoogle Scholar
  42. 42.
    Madsen KL, Doyle JS, Jewell LD, et al.: Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 1999, 116:1246–1249.CrossRefGoogle Scholar
  43. 43.
    Tejada-Simon MV, Lee JH, Ustunol Z, Pestka JJ: Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiate immunoglobulin A responses to cholera toxin in mice. J Dairy Sci 1999, 82:649–660.PubMedCrossRefGoogle Scholar
  44. 44.
    Mercenier A: Lactic acid bacteria as live vaccines. In Probiotics: A Critical Review. Edited by Tannock GW. Wymondham, United Kingdom: Horizon Scientific Press; 1999:113–127. This excellent discussion of lactic acid vaccine developments was written by an author well known in the field.Google Scholar

Copyright information

© Current Science Inc. 2000

Authors and Affiliations

  • Gregor Reid
    • 1
  1. 1.H414, Lawson Research InstituteLondonCanada

Personalised recommendations